Chemotherapy After Stomach Surgery for Cancer
Author Information
Author(s): B Neril, V de Leonardis, S Romano, F Andreoli, LM Pernice, L Bruno, D Borrelli, A Valeri, S Fabbroni, C Intini, G Cini
Primary Institution: University of Florence, Italy
Hypothesis
Does adjuvant chemotherapy improve survival in node-positive gastric cancer patients after surgery?
Conclusion
Adjuvant chemotherapy improves survival rates in node-positive gastric cancer patients after surgery.
Supporting Evidence
- Patients receiving chemotherapy had a median survival of 20.4 months compared to 13.6 months for those who did not.
- Only 10% of treated patients had recurrences compared to 38% of control patients.
- Acute toxicity from chemotherapy was mild and well tolerated.
Takeaway
This study found that giving chemotherapy after stomach surgery helps patients live longer and have fewer cancer recurrences.
Methodology
103 patients were randomized to receive either chemotherapy or no treatment after gastric resection, with follow-up for 36 months.
Limitations
The study's final assessment requires completion of the trial, and the results may not apply to all gastric cancer patients.
Participant Demographics
Patients had histologically proven adenocarcinoma and were node-positive, with a Karnofsky score greater than 60.
Statistical Information
P-Value
p<0.01
Confidence Interval
1.29 to 3.66
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website